CVS HEALTH CORPORATION (CVS) Operating Margin
- Operating margin · 12 months: Value 2.00%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 2.00% | Operating income / revenue. Period ending 2026-06-30. $8.29B ÷ $415.09B × 100 ≈ 2.00% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 8.29B USD | Operating Income (Loss) |
| Revenue | 415.09B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 230.41B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8.29B | $415.09B | $230.41B | (m) | (m) | 2.00% |
| 2026-03-31 | $5.97B | $407.90B | $225.55B | (m) | (m) | 1.46% |
| 2025-12-31 | $4.66B | $402.07B | $221.17B | (m) | (m) | 1.16% |
| 2025-09-30 | $4.92B | $394.08B | $217.38B | (m) | (m) | 1.25% |
| 2025-06-30 | $8.96B | $386.64B | $213.28B | (m) | (m) | 2.32% |
| 2025-03-31 | $9.62B | $378.96B | $209.27B | (m) | (m) | 2.54% |
| 2024-12-31 | $8.52B | $372.81B | $206.29B | (m) | (m) | 2.28% |
| 2024-09-30 | $9.52B | $368.91B | $208.44B | (m) | (m) | 2.58% |
| 2024-06-30 | $12.38B | $363.25B | $210.18B | (m) | (m) | 3.41% |
| 2024-03-31 | $12.57B | $360.94B | $213.72B | (m) | (m) | 3.48% |
| 2023-12-31 | $13.74B | $357.78B | $217.10B | (m) | (m) | 3.84% |
| 2023-09-30 | $14.03B | $347.81B | $211.41B | (m) | (m) | 4.03% |
| 2023-06-30 | $6.42B | $339.20B | $207.08B | (m) | (m) | 1.89% |
| 2023-03-31 | $7.65B | $330.92B | $202.84B | (m) | (m) | 2.31% |
| 2022-12-31 | $7.75B | $322.47B | $196.89B | (m) | (m) | 2.40% |
| 2022-09-30 | $6.36B | $315.23B | $191.54B | (m) | (m) | 2.02% |
| 2022-06-30 | $13.35B | $307.86B | $186.19B | (m) | (m) | 4.34% |
| 2022-03-31 | $13.11B | $299.84B | $180.42B | (m) | (m) | 4.37% |
| 2021-12-31 | $13.19B | $292.11B | $175.80B | (m) | (m) | 4.52% |
| 2021-09-30 | $13.49B | $285.06B | $171.88B | (m) | (m) | 4.73% |
| 2021-06-30 | $13.68B | $278.32B | $167.81B | (m) | (m) | 4.91% |
| 2021-03-31 | $14.03B | $271.05B | $164.53B | (m) | (m) | 5.18% |
| 2020-12-31 | $13.91B | $268.71B | $163.98B | (m) | (m) | 5.18% |
| 2020-09-30 | $14.42B | $266.85B | $163.59B | (m) | (m) | 5.41% |
| 2020-06-30 | $14.10B | $264.34B | $163.09B | (m) | (m) | 5.34% |
| 2020-03-31 | $12.76B | $262.13B | $161.82B | (m) | (m) | 4.87% |
| 2019-12-31 | $11.99B | $256.78B | $158.72B | (m) | (m) | 4.67% |
| 2019-09-30 | $9.77B | $243.33B | $157.22B | (m) | (m) | 4.02% |
| 2019-06-30 | $9.42B | $226.05B | $156.28B | (m) | (m) | 4.17% |
| 2019-03-31 | $4.71B | $209.62B | $156.19B | (m) | (m) | 2.25% |
| 2018-12-31 | $4.02B | $193.92B | $156.45B | (m) | (m) | 2.07% |
| 2018-09-30 | $5.82B | $188.06B | (m) | (m) | (m) | 3.09% |
| 2018-06-30 | $5.97B | $186.97B | (m) | (m) | (m) | 3.19% |
| 2018-03-31 | $9.67B | $185.94B | (m) | (m) | (m) | 5.20% |
| 2017-12-31 | $9.52B | $184.76B | (m) | (m) | (m) | 5.15% |
| 2017-09-30 | $9.38B | $182.35B | (m) | (m) | (m) | 5.14% |
| 2017-06-30 | $9.71B | $180.78B | (m) | (m) | (m) | 5.37% |
| 2017-03-31 | $9.95B | $178.82B | (m) | (m) | (m) | 5.56% |
| 2016-12-31 | $10.34B | $177.53B | (m) | (m) | (m) | 5.82% |
| 2016-09-30 | $10.07B | $172.70B | (m) | (m) | (m) | 5.83% |
| 2016-06-30 | $9.59B | $166.73B | (m) | (m) | (m) | 5.75% |
| 2016-03-31 | $9.50B | $160.17B | (m) | (m) | (m) | 5.93% |
| 2015-12-31 | $9.45B | $153.29B | (m) | (m) | (m) | 6.17% |
| 2015-09-30 | $9.05B | $149.20B | (m) | (m) | (m) | 6.06% |
| 2015-06-30 | $8.96B | $145.58B | (m) | (m) | (m) | 6.16% |
| 2015-03-31 | $8.91B | $143.01B | (m) | (m) | (m) | 6.23% |
| 2014-12-31 | $8.80B | $139.37B | (m) | (m) | (m) | 6.31% |
| 2014-09-30 | $8.70B | $135.14B | (m) | (m) | (m) | 6.43% |
| 2014-06-30 | $8.60B | $132.05B | (m) | (m) | (m) | 6.51% |
| 2014-03-31 | $8.37B | $128.70B | (m) | (m) | (m) | 6.50% |
| 2013-12-31 | $8.04B | $126.76B | (m) | (m) | (m) | 6.34% |
| 2013-09-30 | $8.13B | $125.37B | (m) | (m) | (m) | 6.49% |
| 2013-06-30 | $7.78B | $123.63B | (m) | (m) | (m) | 6.30% |
| 2013-03-31 | $7.52B | $123.10B | (m) | (m) | (m) | 6.11% |
| 2012-12-31 | $7.23B | $123.13B | (m) | (m) | (m) | 5.87% |
| 2012-09-30 | $6.88B | $120.06B | (m) | (m) | (m) | 5.73% |
| 2012-06-30 | $6.65B | $116.50B | (m) | (m) | (m) | 5.71% |
| 2012-03-31 | $6.43B | $112.20B | (m) | (m) | (m) | 5.73% |
| 2011-12-31 | $6.33B | $107.10B | (m) | (m) | (m) | 5.91% |
| 2011-09-30 | $6.16B | $104.01B | (m) | (m) | (m) | 5.92% |
| 2011-06-30 | $6.05B | $101.16B | (m) | (m) | (m) | 5.99% |
| 2011-03-31 | $6.07B | $98.53B | (m) | (m) | (m) | 6.16% |
| 2010-12-31 | $6.17B | $96.41B | (m) | (m) | (m) | 6.39% |
| 2010-09-30 | $6.29B | $97.46B | (m) | (m) | (m) | 6.45% |
| 2010-06-30 | $6.37B | $98.23B | (m) | (m) | (m) | 6.49% |
| 2010-03-31 | $6.47B | $99.09B | (m) | (m) | (m) | 6.53% |
| 2009-12-31 | $6.44B | $98.73B | (m) | (m) | (m) | 6.52% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $6.05B | $87.47B | (m) | (m) | (m) | 6.91% |
| 2008-09-27 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-28 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-29 | $4.79B | $76.33B | (m) | (m) | (m) | 6.28% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |